Gersava, Jheiys Barie M.

HRN: 22-28-61  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/03/2022
CEFTAZIDIME 1GM (VIAL)
12/03/2022
12/10/2022
IV DRIP
550 Mg
Q8
PCAP D
Waiting Final Action 
12/05/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
12/05/2022
12/11/2022
IVT
80mg
Q6hrs
Pcap D
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: